Stay updated on Lenvatinib and Pembrolizumab in DTC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in DTC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A new page revision tag Revision: v3.5.5 was added, replacing the previous tag Revision: v3.5.4. This indicates an updated version of the page content or its documentation.
    Difference
    0.0%
    Check dated 2026-06-05T15:59:58.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page's Revision tag was updated from v3.5.3 to v3.5.4, signaling a newer version of the page has been published. This is a metadata-level update and does not specify which content was modified.
    Difference
    0.0%
    Check dated 2026-05-15T05:51:45.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page’s release/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This reflects a change in the ClinicalTrials.gov page revision, not the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-24T05:39:25.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:20:44.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Added Hurthle cell carcinoma of thyroid and differentiated thyroid carcinoma to the conditions, and included a Resources section with the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T14:52:31.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No user-facing content or functionality is affected.
    Difference
    0.0%
    Check dated 2026-03-18T21:56:12.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in DTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.